11/24/2025
"Richi LifeSciences has been a game changer." That's the resounding feedback from this edition's cohort, and after two transformative weeks in Boston, we couldn't agree more!
The selected companies leave the program having successfully polished their pitches and gained hands-on strategies for US expansion. This second week focused intensely on launching in the US, mastering startup valuation, navigating legal and immigration regulation, and securing funding—including an essential negotiation workshop and a session on non-dilutive funds.
Participants met with numerous investors and industry experts who provided custom project feedback, and they toured state-of-the-art facilities like LabCentral and The Engine.
We extend a huge thank you to all the experts who made the final week so valuable: Robert Gottlieb, Joseph McKneely, Daniel Blanchard, Stan Chalvire, Valerie Vigoda, MBA, CIPP, Chuck Goldstone, Samuel (Mooly) Dinnar, Neal Kalechofsky, Rhett Smith, Felicia Gullotta, Jason Kraus, Ben Littauer, Shmuel Agus, Carles Monterrubio, PhD, Natalie Roy D'Amore, Tim Xu MD MPP, Doug Zingale, and Steve Pemberton.
Congratulations to this incredible cohort! We can't wait to see the breakthrough therapies and innovations you'll bring to patients!